AA
SBIO icon

Ancora Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Ancora Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,258
Closed -$35K – 2144
2022
Q2 		$35K Buy
+1,258
New +$35.9K ﹤0.01% 1275

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
AC
ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return

Ancora Advisors's SBIO Position: Q3 2022 in Review

Ancora Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2022, closing a stake of 1,258 shares — an estimated $35K sold.

Ancora Advisors first reported a position in SBIO in Q2 2022 and held it in 1 quarter. The position peaked at $35K in Q2 2022. 44 funds tracked by Wall St. Rank hold SBIO as of Q3 2022.

  • Ancora Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2022 after selling out during the quarter.
  • Ancora Advisors sold 1,258 ALPS Medical Breakthroughs ETF shares in Q3 2022, an estimated $35K.
  • Ancora Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2022 and held it in 1 quarter.
  • Ancora Advisors's ALPS Medical Breakthroughs ETF position peaked at $35K in Q2 2022.
  • 44 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.